A Study in Adult Patients With Major Depressive Disorder

NCT00795821 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

495

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: LY2216684
DRUG: Placebo

Sponsor

Eli Lilly and Company